Clinical Trials Directory

Trials / Completed

CompletedNCT01334619

Ropivacaine Volume for Ultrasound-guided Retrograde Infraclavicular Brachial Plexus Block

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Beijing Jishuitan Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The retrograde infraclavicular brachial plexus block has been proved an effective and safe approach. Realtime ultrasound guide will facilitate a successful peripheral nerve block. The purpose of this study was to determine the medium effective volume required to produce an effective retrograde infraclavicular block using an ultrasound (US)-guided technique.

Detailed description

Thirty adults undergoing elective upper limb surgery received an US-guided retrograde infraclavicular block. The initial concentration of 0.5% ropivacaine injected was 30 ml, which was subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient. The medium effective volume (EV50) was determined using the Dixon and Massey up-and-down method. The effective volume in 95% of patients (EV95) was calculated using probit regression.

Conditions

Interventions

TypeNameDescription
PROCEDUREappropriate volume of 0.5% ropivacaineinitial concentration: 30 ml, subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient, until 5 up-and-down cycles completed.

Timeline

Start date
2010-03-01
Primary completion
2010-04-01
Completion
2010-05-01
First posted
2011-04-13
Last updated
2011-04-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01334619. Inclusion in this directory is not an endorsement.